Smofkabiven Peripheral 12 mg

SMOFKABIVEN Peripheral 12 mg is an intravenous emulsion containing tyrosine, an essential amino acid. It is designed to support nutritional needs in patients requiring parenteral nutrition. This product is manufactured by Fresenius Kabi Canada Ltd.

SMOFKABIVEN Peripheral 12 mg is used to provide essential amino acids, including tyrosine, to patients who cannot absorb nutrients through the digestive system. Tyrosine is crucial for the synthesis of proteins and certain neurotransmitters. This emulsion is typically used in clinical settings to support nutritional therapy.

The effects of SMOFKABIVEN Peripheral 12 mg include the provision of essential amino acids necessary for protein synthesis and overall nutritional support. Patients may experience improved nutritional status when used as directed by healthcare professionals.

SMOFKABIVEN Peripheral 12 mg should be administered under medical supervision. It is important to follow proper handling and storage guidelines to maintain the integrity of the emulsion. Patients with known allergies to any components should avoid use.

SMOFKABIVEN Peripheral 12 mg may interact with other medications or supplements. It is important to consult with a healthcare provider before combining with other treatments. Always follow the advice of a medical professional regarding potential interactions.